Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret

European Journal of Pharmacology
Kelvin K W KanMan-K Wai


In the present studies we investigated the mechanism of action of prostaglandin E2 (1 mg/kg, i.p.) to induce emesis and defecation and/or tenesmus in the ferret. The emesis was antagonized significantly (P<0.05) by ondansetron (0.3 and 1 mg/kg, i.p.) and (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenlypiperidine hydrochloride (CP-99,994; 10 mg/kg, i.p.), but neither compound reduced defecations and/or tenesmus, with ondansetron (0.3 mg/kg) actually producing a slight increase (P<0.05). Droperidol (1 and 3 mg/kg), metoclopramide (0.3 and 3 mg/kg), domperidone (0.3 and 3 mg/kg), promethazine (0.3 and 3 mg/kg) and scopolamine (0.3 and 3 mg/kg) failed to reduce prostaglandin E2 induced emesis. However, droperidol (1 and 3 mg/kg) and scopolamine (0.3 and 3 mg/kg) reduced significantly the defecatory and/or tenesmus response (P<0.05). Bilateral abdominal vagotomy was ineffective to reduce emesis and defecations and/or tenesmus. The data suggests that 5-HT3 receptor and NK1 tachykinin receptor antagonists could be useful in the clinic to prevent emesis but not defecations induced by prostaglandin E2.


Feb 1, 1977·Prostaglandins·S M Karim, P G Adaikan
Jul 16, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·M Costa, J B Furness
Jan 1, 1992·Prostaglandins, Leukotrienes, and Essential Fatty Acids·V De SaedeleerA Houvenaghel
Feb 1, 1990·Canadian Journal of Physiology and Pharmacology·P L AndrewsL Maskell
Jan 1, 1989·Scandinavian Journal of Gastroenterology. Supplement·G Bianchi Porro, F Parente
Dec 1, 1986·Cellular and Molecular Neurobiology·D B Briggs, D O Carpenter
Jun 1, 1988·British Journal of Pharmacology·A ButlerM B Tyers
Mar 12, 1982·European Journal of Pharmacology·J H ZaveczT O Yellin
Dec 1, 1981·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·K Fahmy
Jan 1, 1982·Psychopharmacology·C J Niemegeers
Oct 26, 1995·Biochimica Et Biophysica Acta·M NegishiA Ichikawa
Jan 1, 1994·Fundamental & Clinical Pharmacology·J L MontastrucJ M Senard
Jun 1, 1994·Journal of Clinical Pharmacology·J J StewartM E Mims
Jul 20, 1993·European Journal of Pharmacology·T KamatoK Miyata
Apr 25, 1996·The New England Journal of Medicine·R K Goyal, I Hirano
Feb 1, 1996·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·T SatoS F Rabito
Jan 7, 1999·Cephalalgia : an International Journal of Headache·C G Dahlöf, R J Hargreaves
Feb 12, 2000·Trends in Pharmacological Sciences·N M Rupniak, M S Kramer
Jul 11, 2002·Life Sciences·Yukinori NagakuraTokio Yamaguchi
Oct 26, 2002·European Journal of Pharmacology·Kelvin K W KanJohn A Rudd
Jan 4, 2003·VASA. Zeitschrift für Gefässkrankheiten·M ReiterE Minar
Dec 9, 2003·European Journal of Pharmacology·Kelvin K W KanMan-K Wai
Apr 23, 2004·European Journal of Pharmacology·Kelvin K W KanJohn A Rudd
Mar 22, 2005·Journal of Magnetic Resonance Imaging : JMRI·Johannes M FroehlichKlaus-Ulrich Wentz

❮ Previous
Next ❯


Jul 12, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Kelvin K W KanJohn A Rudd
Nov 28, 2009·European Journal of Pharmacology·Seetha CheboluNissar A Darmani
Dec 3, 2014·Biochemical and Biophysical Research Communications·Sojin KimYoung-Ho Jin
Apr 13, 2013·Journal of Pharmacological and Toxicological Methods·Sonia GoineauVincent Castagné
Mar 23, 2017·European Journal of Pharmacology·Kelvin K W KanJohn A Rudd
Jun 3, 2021·International Journal of Molecular Sciences·Weixia ZhongNissar A Darmani
Sep 28, 2021·Frontiers in Pharmacology·Weixia Zhong, Nissar A Darmani

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.